Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/1871

TDMS Study 05107-05 Pathology Tables


                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                         NICKEL SUBSULFIDE


NTP Experiment-Test: 05107-05                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 05/19/95
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 22:11:47




       Facility:  Lovelace Inhalation Toxicology Research Institute

       Chemical CAS #:  12035722

       Lock Date:  09/30/92

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All
































a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05107-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         NICKEL SUBSULFIDE                                     Date: 05/19/95  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 22:11:47  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0.0MG/M3     0.0MG/M3     0.15         0.15         1.0          1.0             
                                                                LUNG TOX     MG/M3        LUNG TOX     MG/M3        LUNG TOX        
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          60           10           60           10           60           10           
  Scheduled Sacrifice                                  2            5            2            5            2            5           
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                24                        27                        23                        
    Natural Death                                      4                         1                         1                        
    Accidently Killed                                                                                      1                        
  Survivors                                                                                                                         
    Terminal Sacrifice                                25                        25                        28                        
  Animals Examined Microscopically                    58            5           58            5           58            5           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Colon                             (55)                      (57)                      (58)                      
      Parasite Metazoan                                                                                    1 (2%)                   
   Intestine Large, Rectum                            (46)                      (43)                      (42)                      
      Parasite Metazoan                                                          2 (5%)                                             
   Intestine Large, Cecum                             (54)                      (57)                      (57)                      
      Inflammation                                     1 (2%)                                                                       
      Parasite Metazoan                                2 (4%)                    2 (4%)                    3 (5%)                   
   Intestine Small, Jejunum                           (55)                      (57)                      (57)                      
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
   Intestine Small, Ileum                             (55)                      (57)                      (58)                      
      Hyperplasia, Lymphoid                            3 (5%)                    5 (9%)                    3 (5%)                   
   Liver                                              (58)                      (58)                      (58)         (1)          
      Angiectasis                                      1 (2%)                                                                       
      Basophilic Focus                                47 (81%)                  49 (84%)                  45 (78%)                  
      Clear Cell Focus                                                           1 (2%)                                             
      Degeneration, Cystic                             1 (2%)                    4 (7%)                    2 (3%)                   
      Degeneration, Fatty                             16 (28%)                  12 (21%)                  11 (19%)                  
      Eosinophilic Focus                               3 (5%)                    2 (3%)                    5 (9%)                   
      Granuloma                                                                                            1 (2%)                   
      Hematopoietic Cell Proliferation                                           1 (2%)                    1 (2%)                   
      Hepatodiaphragmatic Nodule                       7 (12%)                   4 (7%)                    2 (3%)                   
      Inflammation, Focal, Granulomatous              24 (41%)                  22 (38%)                  13 (22%)                  
      Inflammation, Granulomatous                      4 (7%)                    2 (3%)                    5 (9%)                   
      Mixed Cell Focus                                 3 (5%)                    1 (2%)                    1 (2%)                   
      Pigmentation, Hemosiderin                        3 (5%)                    1 (2%)                    7 (12%)                  
      Regeneration                                                                                         2 (3%)                   
      Bile Duct, Hyperplasia                          18 (31%)                  13 (22%)                  14 (24%)                  
      Biliary Tract, Hyperplasia                       1 (2%)                                                                       
      Centrilobular, Atrophy                           9 (16%)                   5 (9%)                   14 (24%)                  
      Hepatocyte, Atrophy                                                                                  1 (2%)                   
      Hepatocyte, Hyperplasia                          4 (7%)                    1 (2%)                    1 (2%)                   
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05107-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         NICKEL SUBSULFIDE                                     Date: 05/19/95  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 22:11:47  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0.0MG/M3     0.0MG/M3     0.15         0.15         1.0          1.0             
                                                                LUNG TOX     MG/M3        LUNG TOX     MG/M3        LUNG TOX        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Hepatocyte, Necrosis                             1 (2%)                    1 (2%)                                             
      Vein, Thrombosis                                                                                     1 (2%)                   
   Mesentery                                          (1)                                                 (2)                       
      Necrosis                                                                                             1 (50%)                  
      Fat, Necrosis                                    1 (100%)                                                                     
   Pancreas                                           (58)                      (57)                      (58)                      
      Atrophy                                         10 (17%)                   4 (7%)                   14 (24%)                  
   Stomach, Forestomach                               (58)                      (58)                      (58)                      
      Hyperplasia, Squamous                            2 (3%)                    5 (9%)                    2 (3%)                   
      Inflammation                                     1 (2%)                                                                       
      Ulcer                                            3 (5%)                    1 (2%)                                             
   Tooth                                              (1)                       (1)                                                 
      Peridontal Tissue, Inflammation                  1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                                                                           (1)                       
      Inflammation                                                                                         1 (100%)                 
   Heart                                              (58)                      (58)                      (58)                      
      Cardiomyopathy                                  25 (43%)                  17 (29%)                  18 (31%)                  
      Atrium, Thrombosis                               2 (3%)                    1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (58)                      (58)                      (58)                      
      Degeneration, Cystic                            11 (19%)                  11 (19%)                  19 (33%)                  
      Hyperplasia                                                                                          2 (3%)                   
      Hyperplasia, Focal                               1 (2%)                                              5 (9%)                   
      Necrosis                                                                                             2 (3%)                   
      Vacuolization Cytoplasmic                        4 (7%)                    3 (5%)                    6 (10%)                  
   Adrenal Medulla                                    (58)                      (56)                      (58)                      
      Hyperplasia                                      5 (9%)                   11 (20%)                  16 (28%)                  
   Islets, Pancreatic                                 (58)                      (58)                      (58)                      
      Hyperplasia                                                                1 (2%)                    1 (2%)                   
   Parathyroid Gland                                  (52)                      (55)                      (54)                      
      Hyperplasia                                      1 (2%)                    2 (4%)                    3 (6%)                   
   Pituitary Gland                                    (57)                      (58)                      (58)                      
      Cyst                                                                       1 (2%)                                             
      Pars Distalis, Angiectasis                      21 (37%)                  11 (19%)                  16 (28%)                  
      Pars Distalis, Cyst                              3 (5%)                    3 (5%)                                             
      Pars Distalis, Hyperplasia                      13 (23%)                   5 (9%)                   14 (24%)                  
   Thyroid Gland                                      (56)                      (58)                      (57)                      
      C-Cell, Hyperplasia                             16 (29%)                  12 (21%)                  12 (21%)                  
____________________________________________________________________________________________________________________________________
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05107-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         NICKEL SUBSULFIDE                                     Date: 05/19/95  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 22:11:47  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0.0MG/M3     0.0MG/M3     0.15         0.15         1.0          1.0             
                                                                LUNG TOX     MG/M3        LUNG TOX     MG/M3        LUNG TOX        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (57)                      (57)                      (57)                      
      Hyperplasia, Cystic                              6 (11%)                   5 (9%)                    5 (9%)                   
      Inflammation                                                               1 (2%)                                             
   Ovary                                              (58)         (1)          (58)         (1)          (58)         (1)          
      Atrophy                                                                                              1 (2%)                   
      Cyst                                             5 (9%)       1 (100%)     3 (5%)       1 (100%)     6 (10%)      1 (100%)    
      Inflammation                                                                                         2 (3%)                   
   Uterus                                             (58)                      (58)                      (58)                      
      Cyst                                             1 (2%)                                                                       
      Inflammation                                                                                         1 (2%)                   
      Endometrium, Hyperplasia, Cystic                 3 (5%)                    1 (2%)                    1 (2%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (58)                      (58)                      (58)                      
      Atrophy                                          2 (3%)                                                                       
      Fibrosis                                         2 (3%)                                              3 (5%)                   
      Inflammation, Focal, Granulomatous               4 (7%)                                              1 (2%)                   
      Necrosis                                                                                             1 (2%)                   
      Erythroid Cell, Hyperplasia                                                1 (2%)                                             
      Myeloid Cell, Hyperplasia                                                  2 (3%)                    2 (3%)                   
   Lymph Node                                         (5)                       (3)                       (10)                      
      Pancreatic, Hyperplasia, Lymphoid                                          1 (33%)                   1 (10%)                  
      Pancreatic, Hyperplasia, Macrophage                                                                  1 (10%)                  
      Renal, Hyperplasia, Lymphoid                     1 (20%)                                                                      
   Lymph Node, Bronchial                              (55)         (5)          (54)         (5)          (55)         (5)          
      Hemorrhage, Acute                                                          1 (2%)                                             
      Hyperplasia, Lymphoid                           11 (20%)      2 (40%)     37 (69%)      2 (40%)     38 (69%)      5 (100%)    
      Hyperplasia, Macrophage                          1 (2%)                   18 (33%)                  28 (51%)                  
      Hyperplasia, Plasma Cell                                                                             2 (4%)                   
      Inflammation                                                                                         1 (2%)                   
   Lymph Node, Mandibular                             (49)                      (53)                      (56)                      
      Hyperplasia, Lymphoid                            3 (6%)                    5 (9%)                    1 (2%)                   
      Hyperplasia, Plasma Cell                         3 (6%)                    6 (11%)                   4 (7%)                   
   Lymph Node, Mesenteric                             (57)                      (58)                      (57)                      
      Atrophy                                                                    1 (2%)                                             
      Hyperplasia, Lymphoid                            3 (5%)                    5 (9%)                    6 (11%)                  
      Hyperplasia, Macrophage                          1 (2%)                                              3 (5%)                   
   Lymph Node, Mediastinal                            (51)         (5)          (55)         (4)          (52)         (5)          
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05107-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         NICKEL SUBSULFIDE                                     Date: 05/19/95  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 22:11:47  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0.0MG/M3     0.0MG/M3     0.15         0.15         1.0          1.0             
                                                                LUNG TOX     MG/M3        LUNG TOX     MG/M3        LUNG TOX        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Hyperplasia, Lymphoid                                         1 (20%)     11 (20%)      1 (25%)     21 (40%)      5 (100%)    
      Hyperplasia, Macrophage                          1 (2%)                    5 (9%)                    7 (13%)                  
   Spleen                                             (58)                      (58)                      (58)                      
      Atrophy                                                                    1 (2%)                                             
      Fibrosis                                         2 (3%)                                              2 (3%)                   
      Hematopoietic Cell Proliferation                                           3 (5%)                    3 (5%)                   
      Hemorrhage                                       1 (2%)                                                                       
      Hyperplasia, Lymphoid                            1 (2%)                    1 (2%)                                             
      Pigmentation, Hemosiderin                        7 (12%)                  12 (21%)                   2 (3%)                   
   Thymus                                             (54)                      (56)                      (55)                      
      Degeneration                                     2 (4%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (58)                      (58)                      (58)                      
      Fibrosis                                                                   1 (2%)                                             
      Hyperplasia, Cystic                             11 (19%)                  14 (24%)                  16 (28%)                  
   Skin                                               (58)                      (58)                      (58)                      
      Hyperkeratosis                                   1 (2%)                                                                       
      Inflammation                                     1 (2%)                                              1 (2%)                   
      Ulcer                                                                      1 (2%)                    1 (2%)                   
      Tail, Hyperkeratosis                             1 (2%)                                                                       
      Tail, Inflammation                               1 (2%)                    1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (58)                      (58)                      (58)                      
      Hyperostosis                                     5 (9%)                    3 (5%)                    7 (12%)                  
      Cranium, Hyperostosis                                                                                3 (5%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (58)                      (58)                      (58)                      
      Cyst                                             1 (2%)                                                                       
      Hemorrhage                                       1 (2%)                                                                       
      Hydrocephalus                                    1 (2%)                    1 (2%)                    2 (3%)                   
      Cerebrum, Compression                            5 (9%)                   10 (17%)                   5 (9%)                   
      Gray Matter, Necrosis                                                                                1 (2%)                   
   Spinal Cord                                                                  (1)                                                 
      Degeneration, Secondary Wallerian                                          1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05107-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         NICKEL SUBSULFIDE                                     Date: 05/19/95  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 22:11:47  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0.0MG/M3     0.0MG/M3     0.15         0.15         1.0          1.0             
                                                                LUNG TOX     MG/M3        LUNG TOX     MG/M3        LUNG TOX        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Larynx                                             (57)                      (58)                      (56)                      
      Hyperplasia, Squamous                            1 (2%)                                                                       
      Inflammation                                     2 (4%)                    2 (3%)                    3 (5%)                   
   Lung                                               (58)         (5)          (58)         (5)          (58)         (5)          
      Cyst                                                                                                 1 (2%)                   
      Emphysema                                                                                            1 (2%)                   
      Fibrosis                                                                  50 (86%)                  44 (76%)                  
      Hemorrhage, Acute                                2 (3%)                    3 (5%)                    2 (3%)                   
      Inflammation, Chronic Active                     7 (12%)                  56 (97%)      5 (100%)    56 (97%)      5 (100%)    
      Metaplasia, Osseous                              1 (2%)       1 (20%)      1 (2%)                                             
      Metaplasia, Squamous                                                                                 2 (3%)                   
      Alveolar Epithelium, Hyperplasia, Focal          2 (3%)                   10 (17%)                  11 (19%)                  
      Alveolus, Hyperplasia, Macrophage                9 (16%)                  56 (97%)      5 (100%)    57 (98%)      5 (100%)    
      Alveolus, Proteinosis                            2 (3%)                   54 (93%)      2 (40%)     58 (100%)     5 (100%)    
      Bronchus, Hyperplasia, Lymphoid                                           15 (26%)      1 (20%)     19 (33%)      4 (80%)     
      Interstitium, Infiltration Cellular             28 (48%)      2 (40%)     40 (69%)      5 (100%)    48 (83%)      5 (100%)    
   Nose                                               (58)         (5)          (58)         (5)          (57)         (5)          
      Inflammation, Chronic Active                     9 (16%)      1 (20%)     11 (19%)      2 (40%)     22 (39%)      4 (80%)     
      Thrombosis                                       2 (3%)                                              1 (2%)                   
      Nasolacrimal Duct, Hyperplasia                                             1 (2%)                                             
      Nasolacrimal Duct, Inflammation                  1 (2%)                    2 (3%)                    2 (4%)                   
      Olfactory Epithelium, Atrophy                                                                       17 (30%)                  
      Olfactory Epithelium, Erosion, Focal                          1 (20%)                   2 (40%)                               
      Olfactory Epithelium, Metaplasia                                           1 (2%)                    1 (2%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (2)                       (2)          (1)          (2)                       
      Cataract                                         2 (100%)                  2 (100%)                  2 (100%)                 
      Retina, Degeneration                             2 (100%)                  1 (50%)                                            
   Lacrimal Gland                                                                                         (1)                       
      Metaplasia, Squamous                                                                                 1 (100%)                 
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (58)         (5)          (58)         (5)          (58)         (5)          
      Cyst                                             1 (2%)                                                                       
      Hydronephrosis                                                                                       1 (2%)                   
      Nephropathy                                     52 (90%)                  54 (93%)                  52 (90%)                  
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05107-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         NICKEL SUBSULFIDE                                     Date: 05/19/95  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 22:11:47  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0.0MG/M3     0.0MG/M3     0.15         0.15         1.0          1.0             
                                                                LUNG TOX     MG/M3        LUNG TOX     MG/M3        LUNG TOX        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Renal Tubule, Pigmentation                      40 (69%)                  43 (74%)                  43 (74%)                  
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05107-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         NICKEL SUBSULFIDE                                     Date: 05/19/95  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 22:11:47  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0.0MG/M3     0.0MG/M3     0.15         0.15         1.0          1.0             
                                                                LUNG TOX     MG/M3        LUNG TOX     MG/M3        LUNG TOX        
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          60           10           60           10           60           10           
  Scheduled Sacrifice                                  5            5            5            5            5            5           
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                35                        28                        33                        
    Natural Death                                      5                         4                         2                        
  Survivors                                                                                                                         
    Terminal Sacrifice                                13                        21                        18                        
  Animals Examined Microscopically                    58            5           58            5           58            5           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Colon                             (56)                      (56)                      (58)                      
      Inflammation                                     3 (5%)                                                                       
      Mineralization                                   1 (2%)                                                                       
      Parasite Metazoan                                                          1 (2%)                    1 (2%)                   
   Intestine Large, Rectum                            (51)                      (50)                      (57)                      
      Inflammation                                     1 (2%)                                                                       
      Parasite Metazoan                                4 (8%)                    1 (2%)                    2 (4%)                   
   Intestine Large, Cecum                             (56)                      (54)                      (57)                      
      Hyperplasia, Lymphoid                            1 (2%)                                              1 (2%)                   
      Inflammation                                     2 (4%)                                              4 (7%)                   
      Parasite Metazoan                                1 (2%)                    2 (4%)                    1 (2%)                   
   Intestine Small, Duodenum                          (57)                      (57)                      (58)                      
      Ulcer                                                                                                2 (3%)                   
   Intestine Small, Jejunum                           (56)                      (56)                      (57)                      
      Hyperplasia, Lymphoid                            1 (2%)                                                                       
   Intestine Small, Ileum                             (56)                      (56)                      (57)                      
      Hyperplasia, Lymphoid                            4 (7%)                    5 (9%)                    3 (5%)                   
   Liver                                              (58)                      (58)                      (58)                      
      Angiectasis                                      3 (5%)                    1 (2%)                                             
      Basophilic Focus                                29 (50%)                  35 (60%)                  35 (60%)                  
      Clear Cell Focus                                 1 (2%)                    1 (2%)                                             
      Degeneration, Cystic                            11 (19%)                  15 (26%)                  15 (26%)                  
      Degeneration, Fatty                              9 (16%)                   2 (3%)                    7 (12%)                  
      Eosinophilic Focus                               6 (10%)                   6 (10%)                   6 (10%)                  
      Hepatodiaphragmatic Nodule                       3 (5%)                    2 (3%)                    4 (7%)                   
      Infiltration Cellular, Mononuclear Cell                                                              1 (2%)                   
      Inflammation, Focal, Granulomatous               1 (2%)                    2 (3%)                    1 (2%)                   
      Pigmentation, Hemosiderin                                                                            1 (2%)                   
      Thrombosis                                                                                           1 (2%)                   
      Bile Duct, Hyperplasia                          40 (69%)                  45 (78%)                  39 (67%)                  
      Biliary Tract, Hyperplasia                       1 (2%)                                                                       
      Centrilobular, Atrophy                          12 (21%)                  16 (28%)                  13 (22%)                  
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05107-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         NICKEL SUBSULFIDE                                     Date: 05/19/95  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 22:11:47  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0.0MG/M3     0.0MG/M3     0.15         0.15         1.0          1.0             
                                                                LUNG TOX     MG/M3        LUNG TOX     MG/M3        LUNG TOX        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Hepatocyte, Hyperplasia                          3 (5%)                    1 (2%)                    2 (3%)                   
      Hepatocyte, Necrosis                             4 (7%)                    7 (12%)                   4 (7%)                   
   Mesentery                                          (1)                       (1)                       (1)                       
      Inflammation                                                                                         1 (100%)                 
      Fat, Necrosis                                                              1 (100%)                                           
   Pancreas                                           (58)                      (58)                      (58)                      
      Atrophy                                         15 (26%)                  15 (26%)                  25 (43%)                  
      Hyperplasia                                                                1 (2%)                                             
   Salivary Glands                                    (58)                      (57)                      (58)                      
      Infarct                                                                    1 (2%)                    1 (2%)                   
   Stomach, Forestomach                               (58)                      (58)                      (58)                      
      Diverticulum                                                               1 (2%)                                             
      Hyperkeratosis                                   1 (2%)                    3 (5%)                                             
      Hyperplasia, Squamous                            1 (2%)                                              5 (9%)                   
      Mineralization                                   1 (2%)                                                                       
      Ulcer                                            4 (7%)                    1 (2%)                    6 (10%)                  
   Stomach, Glandular                                 (58)                      (58)                      (58)                      
      Necrosis, Focal                                  1 (2%)                    2 (3%)                    3 (5%)                   
      Epithelium, Mineralization                       1 (2%)                    1 (2%)                                             
   Tooth                                              (1)                       (1)                       (1)                       
      Dysplasia                                        1 (100%)                  1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (1)                                                 (1)                       
      Inflammation                                                                                         1 (100%)                 
      Mineralization                                   1 (100%)                                                                     
   Heart                                              (58)                      (58)                      (58)                      
      Cardiomyopathy                                  37 (64%)                  37 (64%)                  36 (62%)                  
      Embolus                                          1 (2%)                                                                       
      Inflammation                                     2 (3%)                                                                       
      Mineralization                                   1 (2%)                                              1 (2%)                   
      Atrium, Thrombosis                               7 (12%)                   6 (10%)                   4 (7%)                   
      Valve, Thrombosis                                                                                    1 (2%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (57)                      (58)                      (58)                      
      Atrophy                                                                    1 (2%)                                             
      Degeneration, Cystic                             2 (4%)                    3 (5%)                    5 (9%)                   
      Hyperplasia, Diffuse                             1 (2%)                                                                       
      Hyperplasia, Focal                               3 (5%)                    2 (3%)                    2 (3%)                   
      Necrosis                                         2 (4%)                                              1 (2%)                   
      Vacuolization Cytoplasmic                       23 (40%)                   7 (12%)                  12 (21%)                  
   Adrenal Medulla                                    (58)                      (57)                      (58)                      
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05107-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         NICKEL SUBSULFIDE                                     Date: 05/19/95  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 22:11:47  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0.0MG/M3     0.0MG/M3     0.15         0.15         1.0          1.0             
                                                                LUNG TOX     MG/M3        LUNG TOX     MG/M3        LUNG TOX        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Hyperplasia                                     26 (45%)                  22 (39%)                  11 (19%)                  
      Bilateral, Thrombosis                                                                                1 (2%)                   
   Islets, Pancreatic                                 (58)                      (58)                      (58)                      
      Hyperplasia                                      1 (2%)                                              1 (2%)                   
   Parathyroid Gland                                  (55)                      (55)                      (56)                      
      Hyperplasia                                      8 (15%)                   6 (11%)                   1 (2%)                   
   Pituitary Gland                                    (58)                      (57)                      (58)                      
      Cyst                                                                                                 1 (2%)                   
      Pars Distalis, Angiectasis                       4 (7%)                    9 (16%)                   3 (5%)                   
      Pars Distalis, Cyst                              1 (2%)                    1 (2%)                    3 (5%)                   
      Pars Distalis, Hyperplasia                      17 (29%)                  12 (21%)                  13 (22%)                  
   Thyroid Gland                                      (57)                      (58)                      (58)                      
      C-Cell, Hyperplasia                              7 (12%)                   8 (14%)                   7 (12%)                  
      Follicle, Hyperplasia                            1 (2%)                                                                       
      Follicular Cell, Hyperplasia                     1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Coagulating Gland                                  (39)                      (47)                      (48)                      
      Inflammation                                     1 (3%)                    3 (6%)                    1 (2%)                   
   Epididymis                                         (58)                      (58)                      (58)                      
      Granuloma Sperm                                                            3 (5%)                                             
      Inflammation                                                                                         1 (2%)                   
   Penis                                              (2)                                                 (1)                       
      Concretion                                       2 (100%)                                                                     
   Preputial Gland                                    (58)                      (58)                      (58)         (1)          
      Ectasia                                          2 (3%)                    1 (2%)                    2 (3%)       1 (100%)    
      Hyperplasia                                      3 (5%)                    1 (2%)                    1 (2%)                   
      Inflammation                                     2 (3%)                    6 (10%)                   4 (7%)                   
   Prostate                                           (58)                      (58)                      (58)                      
      Inflammation                                     2 (3%)                    3 (5%)                                             
   Seminal Vesicle                                    (57)                      (58)                      (57)                      
      Atrophy                                          1 (2%)                    2 (3%)                    2 (4%)                   
      Epithelium, Hyperplasia                                                                              1 (2%)                   
   Testes                                             (58)                      (58)                      (58)                      
      Germinal Epithelium, Degeneration                7 (12%)                  13 (22%)                  13 (22%)                  
      Interstitial Cell, Hyperplasia                  14 (24%)                  16 (28%)                  18 (31%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 05107-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         NICKEL SUBSULFIDE                                     Date: 05/19/95  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 22:11:47  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0.0MG/M3     0.0MG/M3     0.15         0.15         1.0          1.0             
                                                                LUNG TOX     MG/M3        LUNG TOX     MG/M3        LUNG TOX        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (58)                      (57)                      (58)                      
      Atrophy                                          4 (7%)                    3 (5%)                    2 (3%)                   
      Fibrosis                                         2 (3%)                                              1 (2%)                   
      Granuloma                                                                                            1 (2%)                   
      Inflammation, Focal, Granulomatous               1 (2%)                    1 (2%)                                             
      Inflammation, Suppurative                                                                            1 (2%)                   
      Necrosis                                         1 (2%)                    1 (2%)                                             
      Myeloid Cell, Hyperplasia                        1 (2%)                    1 (2%)                    5 (9%)                   
   Lymph Node                                         (5)                       (16)                      (6)                       
      Iliac, Hyperplasia, Lymphoid                                               1 (6%)                                             
      Pancreatic, Hyperplasia, Lymphoid                                                                    1 (17%)                  
      Renal, Angiectasis                               1 (20%)                                                                      
      Renal, Pigmentation                                                        1 (6%)                                             
   Lymph Node, Bronchial                              (57)         (4)          (56)         (5)          (57)         (5)          
      Angiectasis                                      1 (2%)                                                                       
      Ectasia                                                                    1 (2%)                                             
      Hyperplasia, Lymphoid                            5 (9%)                   34 (61%)      4 (80%)     38 (67%)      5 (100%)    
      Hyperplasia, Macrophage                          1 (2%)                   18 (32%)                  32 (56%)                  
      Hyperplasia, Plasma Cell                         1 (2%)                    1 (2%)                    1 (2%)                   
   Lymph Node, Mandibular                             (55)                      (56)                      (54)                      
      Hyperplasia, Lymphoid                            4 (7%)                    7 (13%)                   3 (6%)                   
      Hyperplasia, Plasma Cell                         6 (11%)                  10 (18%)                   4 (7%)                   
      Inflammation                                     2 (4%)                                                                       
   Lymph Node, Mesenteric                             (58)                      (58)                      (58)                      
      Angiectasis                                      1 (2%)                                                                       
      Atrophy                                          1 (2%)                                                                       
      Hyperplasia, Lymphoid                            5 (9%)                   11 (19%)                   6 (10%)                  
      Hyperplasia, Macrophage                                                                              1 (2%)                   
      Inflammation                                     1 (2%)                                                                       
   Lymph Node, Mediastinal                            (53)         (5)          (54)         (5)          (53)         (5)          
      Angiectasis                                      1 (2%)                                                                       
      Hyperplasia, Lymphoid                            1 (2%)                   15 (28%)      5 (100%)     9 (17%)      3 (60%)     
      Hyperplasia, Macrophage                                                    2 (4%)                                             
      Inflammation                                     1 (2%)                                                                       
   Spleen                                             (58)                      (58)                      (58)                      
      Atrophy                                          3 (5%)                    2 (3%)                    1 (2%)                   
      Fibrosis                                        10 (17%)                  13 (22%)                  12 (21%)                  
      Hematopoietic Cell Proliferation                 2 (3%)                                                                       
      Hemorrhage                                                                                           1 (2%)                   
      Hyperplasia, Lymphoid                                                      4 (7%)                    1 (2%)                   
      Infarct                                                                    2 (3%)                                             
      Pigmentation, Hemosiderin                                                  2 (3%)                    3 (5%)                   
   Thymus                                             (55)                      (53)                      (53)                      
      Degeneration                                    17 (31%)                   3 (6%)                   10 (19%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
NTP Experiment-Test: 05107-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         NICKEL SUBSULFIDE                                     Date: 05/19/95  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 22:11:47  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0.0MG/M3     0.0MG/M3     0.15         0.15         1.0          1.0             
                                                                LUNG TOX     MG/M3        LUNG TOX     MG/M3        LUNG TOX        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (53)                      (53)                      (48)                      
      Hyperplasia, Cystic                              8 (15%)                   2 (4%)                    2 (4%)                   
   Skin                                               (58)                      (58)                      (58)                      
      Cyst Epithelial Inclusion                        2 (3%)                    1 (2%)                    1 (2%)                   
      Conjunctiva, Inflammation                        1 (2%)                                                                       
      Dermis, Inflammation                             1 (2%)                                                                       
      Subcutaneous Tissue, Inflammation                                                                    1 (2%)                   
      Tail, Hyperkeratosis                                                       1 (2%)                    1 (2%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (58)                      (57)                      (58)                      
      Fibrous Osteodystrophy                           1 (2%)                                                                       
      Hyperostosis                                     1 (2%)                    4 (7%)                    1 (2%)                   
      Mandible, Necrosis                                                                                   1 (2%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (58)                      (58)                      (58)                      
      Compression                                      1 (2%)                                                                       
      Cyst                                                                                                 1 (2%)                   
      Embolus                                          1 (2%)                                                                       
      Necrosis                                         1 (2%)                                                                       
      Cerebrum, Atrophy, Focal                                                                             1 (2%)                   
      Cerebrum, Compression                            6 (10%)                   4 (7%)                    4 (7%)                   
      Gray Matter, Necrosis                            1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Larynx                                             (54)                      (57)                      (57)                      
      Hyperplasia                                      4 (7%)                                                                       
      Inflammation                                     3 (6%)                    2 (4%)                    2 (4%)                   
   Lung                                               (58)         (5)          (58)         (5)          (58)         (5)          
      Embolus                                          1 (2%)                                                                       
      Emphysema                                                                  1 (2%)                    1 (2%)                   
      Fibrosis                                         2 (3%)                   48 (83%)                  40 (69%)                  
      Hemorrhage, Acute                                7 (12%)                   1 (2%)                                             
      Inflammation, Chronic Active                     9 (16%)      1 (20%)     58 (100%)     5 (100%)    56 (97%)      5 (100%)    
      Metaplasia, Osseous                              2 (3%)                    2 (3%)       1 (20%)      2 (3%)                   
      Metaplasia, Squamous                                                       2 (3%)                                             
      Mineralization                                   1 (2%)                                              1 (2%)                   
      Alveolar Epithelium, Hyperplasia, Focal          2 (3%)                    6 (10%)                  11 (19%)                  
      Alveolus, Emphysema                                                                                  1 (2%)                   
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   12                                                              
NTP Experiment-Test: 05107-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         NICKEL SUBSULFIDE                                     Date: 05/19/95  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 22:11:47  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0.0MG/M3     0.0MG/M3     0.15         0.15         1.0          1.0             
                                                                LUNG TOX     MG/M3        LUNG TOX     MG/M3        LUNG TOX        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Alveolus, Hyperplasia, Macrophage               10 (17%)                  53 (91%)      5 (100%)    57 (98%)      5 (100%)    
      Alveolus, Proteinosis                            1 (2%)                   41 (71%)      3 (60%)     56 (97%)      5 (100%)    
      Bronchus, Hyperplasia, Lymphoid                                           10 (17%)      1 (20%)     14 (24%)      4 (80%)     
      Interstitium, Infiltration Cellular             19 (33%)      3 (60%)     35 (60%)      5 (100%)    43 (74%)      5 (100%)    
   Nose                                               (58)         (5)          (58)         (5)          (57)         (5)          
      Inflammation, Acute                                                        1 (2%)                                             
      Inflammation, Chronic Active                    13 (22%)                  12 (21%)                  18 (32%)      3 (60%)     
      Thrombosis                                       3 (5%)                    3 (5%)                    4 (7%)                   
      Nasolacrimal Duct, Inflammation                                                                      3 (5%)                   
      Olfactory Epithelium, Atrophy                    2 (3%)                    1 (2%)                    9 (16%)      1 (20%)     
      Olfactory Epithelium, Mineralization, Focal      1 (2%)                                              3 (5%)                   
      Respiratory Epithelium, Hyperplasia                                                                               1 (20%)     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (4)                       (4)                       (3)                       
      Cataract                                         1 (25%)                   2 (50%)                                            
      Inflammation                                     1 (25%)                                                                      
      Phthisis Bulbi                                   1 (25%)                                                                      
      Anterior Chamber, Hemorrhage, Chronic                                      1 (25%)                                            
      Iris, Inflammation                                                         1 (25%)                                            
      Retina, Degeneration                                                       3 (75%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (57)         (5)          (58)         (5)          (58)         (5)          
      Cyst                                             1 (2%)                    2 (3%)                    2 (3%)                   
      Embolus                                          1 (2%)                                                                       
      Hydronephrosis                                                                                       1 (2%)                   
      Infarct                                          1 (2%)                                              1 (2%)                   
      Inflammation                                     1 (2%)                                                                       
      Mineralization                                   1 (2%)                                              1 (2%)                   
      Nephropathy                                     56 (98%)                  58 (100%)                 58 (100%)                 
      Cortex, Infarct                                                                                      2 (3%)                   
      Papilla, Necrosis                                                                                    1 (2%)                   
      Renal Tubule, Pigmentation                      20 (35%)                  35 (60%)                  35 (60%)                  
   Urethra                                                                      (1)                                                 
      Calculus Micro Observation Only                                            1 (100%)                                           
   Urinary Bladder                                    (58)         (3)          (58)         (4)          (58)         (5)          
      Calculus Gross Observation                       4 (7%)                    2 (3%)                                             
      Calculus Micro Observation Only                  5 (9%)       2 (67%)      3 (5%)       4 (100%)     3 (5%)       5 (100%)    
      Congestion                                       1 (2%)                                                                       
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   13                                                              
NTP Experiment-Test: 05107-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         NICKEL SUBSULFIDE                                     Date: 05/19/95  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 22:11:47  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0.0MG/M3     0.0MG/M3     0.15         0.15         1.0          1.0             
                                                                LUNG TOX     MG/M3        LUNG TOX     MG/M3        LUNG TOX        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Inflammation                                                                                         3 (5%)                   
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   14                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------